| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |